Project Start
1997-04-01
Project End
Budget Start
1997-04-01
Budget End
1997-09-30
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Ren, Yi A; Mullany, Lisa K; Liu, Zhilin et al. (2016) Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones. Cancer Res 76:2206-18
Ren, Yi A; Liu, Zhilin; Mullany, Lisa K et al. (2016) Growth Arrest Specific-1 (GAS1) Is a C/EBP Target Gene That Functions in Ovulation and Corpus Luteum Formation in Mice. Biol Reprod 94:44
Mullany, Lisa K; Wong, Kwong-Kwok; Marciano, David C et al. (2015) Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival. Neoplasia 17:789-803
Richards, J S; Fan, H-Y; Liu, Z et al. (2012) Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis. Oncogene 31:1504-20
Richards, Joanne S; Pangas, Stephanie A (2010) New insights into ovarian function. Handb Exp Pharmacol :3-27
Richards, Joanne S; Pangas, Stephanie A (2010) The ovary: basic biology and clinical implications. J Clin Invest 120:963-72
Oh, S P; Li, E (1997) The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev 11:1812-26
Lei, H; Oh, S P; Okano, M et al. (1996) De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122:3195-205
Themmen, A P; Hinrichs, V; Birnbaumer, M (1993) In situ assay of hormone-stimulated adenylyl cyclase in 96-well microtitration plates: an aide to rapid identification of transformed cell clones. J Recept Res 13:69-78
Birnbaumer, M; Hinrichs, V; Themmen, A P et al. (1990) Development and characterization of a mouse cell line expressing the human V2 vasopressin receptor gene. Mol Endocrinol 4:245-54